In line with this, miR-96-5p expression is upregulated in serum and tumoral tissues of ovarian cancer patients, and miR-96-5p increases the proliferation of ovarian cancer cells via increasing the AKT phosphorylation and cyclin D1 expression (Liu et al., 2019[72]). Here, CCND1 is linked to ovarian carcinoma.